Celltech Therapeutics Ltd. regulatory update

CTP received a notice of allowance for its "Adair" patent in the U.S. The patent, which corresponds to one already issued by the European Patent Office, is expected to be issued early in 1997. CTP said the patent covers all of its antibodies in clinical development, as well as a range of antibodies in development by other companies. ...